Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Adaptimmune Therapeutics PLC
Change in Working Capital
Adaptimmune Therapeutics PLC
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
Change in Working Capital
$28.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Change in Working Capital
-$43.5m
|
CAGR 3-Years
-329%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Change in Working Capital
$292k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Change in Working Capital
$38m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Change in Working Capital
£5.8m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Change in Working Capital
-£37m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-15%
|
See Also
What is Adaptimmune Therapeutics PLC's Change in Working Capital?
Change in Working Capital
28.1m
USD
Based on the financial report for Mar 31, 2024, Adaptimmune Therapeutics PLC's Change in Working Capital amounts to 28.1m USD.